BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 33824342)

  • 1. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.
    Ogbe A; Kronsteiner B; Skelly DT; Pace M; Brown A; Adland E; Adair K; Akhter HD; Ali M; Ali SE; Angyal A; Ansari MA; Arancibia-Cárcamo CV; Brown H; Chinnakannan S; Conlon C; de Lara C; de Silva T; Dold C; Dong T; Donnison T; Eyre D; Flaxman A; Fletcher H; Gardner J; Grist JT; Hackstein CP; Jaruthamsophon K; Jeffery K; Lambe T; Lee L; Li W; Lim N; Matthews PC; Mentzer AJ; Moore SC; Naisbitt DJ; Ogese M; Ogg G; Openshaw P; Pirmohamed M; Pollard AJ; Ramamurthy N; Rongkard P; Rowland-Jones S; Sampson O; Screaton G; Sette A; Stafford L; Thompson C; Thomson PJ; Thwaites R; Vieira V; Weiskopf D; Zacharopoulou P; ; ; Turtle L; Klenerman P; Goulder P; Frater J; Barnes E; Dunachie S
    Nat Commun; 2021 Apr; 12(1):2055. PubMed ID: 33824342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-γ
    Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
    Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay.
    Cassaniti I; Percivalle E; Bergami F; Piralla A; Comolli G; Bruno R; Vecchia M; Sambo M; Colaneri M; Zuccaro V; Benazzo M; Robotti C; Calastri A; Maiorano E; Ferrari A; Cambiè G; Baldanti F
    Clin Microbiol Infect; 2021 Jul; 27(7):1029-1034. PubMed ID: 33813122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition.
    Nelde A; Bilich T; Heitmann JS; Maringer Y; Salih HR; Roerden M; Lübke M; Bauer J; Rieth J; Wacker M; Peter A; Hörber S; Traenkle B; Kaiser PD; Rothbauer U; Becker M; Junker D; Krause G; Strengert M; Schneiderhan-Marra N; Templin MF; Joos TO; Kowalewski DJ; Stos-Zweifel V; Fehr M; Rabsteyn A; Mirakaj V; Karbach J; Jäger E; Graf M; Gruber LC; Rachfalski D; Preuß B; Hagelstein I; Märklin M; Bakchoul T; Gouttefangeas C; Kohlbacher O; Klein R; Stevanović S; Rammensee HG; Walz JS
    Nat Immunol; 2021 Jan; 22(1):74-85. PubMed ID: 32999467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection.
    Jiang XL; Wang GL; Zhao XN; Yan FH; Yao L; Kou ZQ; Ji SX; Zhang XL; Li CB; Duan LJ; Li Y; Zhang YW; Duan Q; Wang TC; Li ET; Wei X; Wang QY; Wang XF; Sun WY; Gao YW; Kang DM; Zhang JY; Ma MJ
    Nat Commun; 2021 Feb; 12(1):897. PubMed ID: 33563974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
    Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Assessment of SARS-CoV-2-Specific T Cell Cytokine-Producing Responses for 1 Year Reveals Persistence of Multicytokine Proliferative Responses, with Greater Immunity Associated with Disease Severity.
    Lin J; Law R; Korosec CS; Zhou C; Koh WH; Ghaemi MS; Samaan P; Ooi HK; Matveev V; Yue F; Gingras AC; Estacio A; Buchholz M; Cheatley PL; Mohammadi A; Kaul R; Pavinski K; Mubareka S; McGeer AJ; Leis JA; Heffernan JM; Ostrowski M
    J Virol; 2022 Jul; 96(13):e0050922. PubMed ID: 35699447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay.
    Echeverría G; Guevara Á; Coloma J; Ruiz AM; Vasquez MM; Tejera E; de Waard JH
    Int J Infect Dis; 2021 Apr; 105():21-25. PubMed ID: 33582369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deconvoluting the T Cell Response to SARS-CoV-2: Specificity Versus Chance and Cognate Cross-Reactivity.
    Lehmann AA; Kirchenbaum GA; Zhang T; Reche PA; Lehmann PV
    Front Immunol; 2021; 12():635942. PubMed ID: 34127926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential T-Cell Reactivity to Endemic Coronaviruses and SARS-CoV-2 in Community and Health Care Workers.
    da Silva Antunes R; Pallikkuth S; Williams E; Dawen Yu E; Mateus J; Quiambao L; Wang E; Rawlings SA; Stadlbauer D; Jiang K; Amanat F; Arnold D; Andrews D; Fuego I; Dan JM; Grifoni A; Weiskopf D; Krammer F; Crotty S; Hoffer ME; Pahwa SG; Sette A
    J Infect Dis; 2021 Jul; 224(1):70-80. PubMed ID: 33822097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of Serum Cross-Reactive Antibodies and Memory Response to SARS-CoV-2 in Prepandemic and Post-COVID-19 Convalescent Samples.
    Shrwani K; Sharma R; Krishnan M; Jones T; Mayora-Neto M; Cantoni D; Temperton NJ; Dobson SL; Subramaniam K; McNamara PS; Cunliffe NA; Turtle L; Zhang Q
    J Infect Dis; 2021 Oct; 224(8):1305-1315. PubMed ID: 34161567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive and mono-reactive SARS-CoV-2 CD4+ T cells in prepandemic and COVID-19 convalescent individuals.
    Johansson AM; Malhotra U; Kim YG; Gomez R; Krist MP; Wald A; Koelle DM; Kwok WW
    PLoS Pathog; 2021 Dec; 17(12):e1010203. PubMed ID: 34965282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents.
    Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P
    Front Immunol; 2021; 12():797919. PubMed ID: 34975908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma.
    Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V
    J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of pre-existing and induced SARS-CoV-2-specific CD8
    Schulien I; Kemming J; Oberhardt V; Wild K; Seidel LM; Killmer S; Sagar ; Daul F; Salvat Lago M; Decker A; Luxenburger H; Binder B; Bettinger D; Sogukpinar O; Rieg S; Panning M; Huzly D; Schwemmle M; Kochs G; Waller CF; Nieters A; Duerschmied D; Emmerich F; Mei HE; Schulz AR; Llewellyn-Lacey S; Price DA; Boettler T; Bengsch B; Thimme R; Hofmann M; Neumann-Haefelin C
    Nat Med; 2021 Jan; 27(1):78-85. PubMed ID: 33184509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral and lung resident memory T cell responses against SARS-CoV-2.
    Grau-Expósito J; Sánchez-Gaona N; Massana N; Suppi M; Astorga-Gamaza A; Perea D; Rosado J; Falcó A; Kirkegaard C; Torrella A; Planas B; Navarro J; Suanzes P; Álvarez-Sierra D; Ayora A; Sansano I; Esperalba J; Andrés C; Antón A; Ramón Y Cajal S; Almirante B; Pujol-Borrell R; Falcó V; Burgos J; Buzón MJ; Genescà M
    Nat Commun; 2021 May; 12(1):3010. PubMed ID: 34021148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent Memory T Cell Immunity in Individuals with Mild or Asymptomatic SARS-CoV-2 Infection May Result from an Evolutionarily Adapted Immune Response to Coronavirus and the 'Common Cold'.
    Stefano GB; Kream RM
    Med Sci Monit; 2020 Nov; 26():e929789. PubMed ID: 33239605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-Avidity CD4
    Bacher P; Rosati E; Esser D; Martini GR; Saggau C; Schiminsky E; Dargvainiene J; Schröder I; Wieters I; Khodamoradi Y; Eberhardt F; Vehreschild MJGT; Neb H; Sonntagbauer M; Conrad C; Tran F; Rosenstiel P; Markewitz R; Wandinger KP; Augustin M; Rybniker J; Kochanek M; Leypoldt F; Cornely OA; Koehler P; Franke A; Scheffold A
    Immunity; 2020 Dec; 53(6):1258-1271.e5. PubMed ID: 33296686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.